Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Methamphetamine | 19 | 2015 | 48 | 5.940 |
Why?
|
Central Nervous System Stimulants | 13 | 2013 | 52 | 3.290 |
Why?
|
Globus Pallidus | 11 | 2013 | 31 | 3.150 |
Why?
|
Rats, Sprague-Dawley | 38 | 2016 | 452 | 2.960 |
Why?
|
Rats | 38 | 2015 | 857 | 2.730 |
Why?
|
Conditioning, Operant | 9 | 2015 | 15 | 2.720 |
Why?
|
Motor Activity | 14 | 2016 | 369 | 2.720 |
Why?
|
Animals | 50 | 2020 | 4577 | 2.450 |
Why?
|
Behavior, Animal | 9 | 2015 | 107 | 2.220 |
Why?
|
Mianserin | 6 | 2016 | 15 | 2.150 |
Why?
|
Morphine | 7 | 2013 | 79 | 1.940 |
Why?
|
Dopamine Agonists | 5 | 2020 | 46 | 1.920 |
Why?
|
Cocaine | 5 | 2017 | 46 | 1.800 |
Why?
|
Dopamine | 6 | 2020 | 156 | 1.760 |
Why?
|
Nucleus Accumbens | 8 | 2015 | 25 | 1.760 |
Why?
|
Impulsive Behavior | 5 | 2016 | 21 | 1.710 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 5 | 2015 | 16 | 1.680 |
Why?
|
Antidepressive Agents, Tricyclic | 4 | 2016 | 23 | 1.430 |
Why?
|
Association Learning | 5 | 2013 | 14 | 1.420 |
Why?
|
Brain | 8 | 2017 | 1689 | 1.370 |
Why?
|
Synaptic Transmission | 5 | 2015 | 46 | 1.310 |
Why?
|
Cerebral Cortex | 3 | 2015 | 195 | 1.270 |
Why?
|
HIV-1 | 4 | 2015 | 438 | 1.260 |
Why?
|
Cocaine-Related Disorders | 3 | 2017 | 18 | 1.220 |
Why?
|
Neurons | 8 | 2014 | 374 | 1.210 |
Why?
|
Choice Behavior | 3 | 2015 | 56 | 1.170 |
Why?
|
Behavior, Addictive | 2 | 2020 | 11 | 1.150 |
Why?
|
Motivation | 4 | 2015 | 100 | 1.120 |
Why?
|
Limbic System | 3 | 2013 | 11 | 1.100 |
Why?
|
Disruptive, Impulse Control, and Conduct Disorders | 3 | 2017 | 10 | 1.090 |
Why?
|
Male | 41 | 2016 | 15627 | 1.070 |
Why?
|
Prefrontal Cortex | 4 | 2015 | 154 | 1.060 |
Why?
|
Benzothiazoles | 2 | 2016 | 20 | 1.000 |
Why?
|
Receptor, Serotonin, 5-HT2C | 2 | 2014 | 2 | 0.990 |
Why?
|
Receptors, Metabotropic Glutamate | 3 | 2013 | 18 | 0.990 |
Why?
|
Parkinson Disease, Secondary | 3 | 2014 | 29 | 0.930 |
Why?
|
Corpus Striatum | 5 | 2016 | 111 | 0.920 |
Why?
|
Receptors, AMPA | 3 | 2013 | 13 | 0.910 |
Why?
|
Self Administration | 10 | 2015 | 36 | 0.900 |
Why?
|
Calcium Channels, L-Type | 2 | 2014 | 60 | 0.900 |
Why?
|
Action Potentials | 6 | 2015 | 144 | 0.870 |
Why?
|
Substance-Related Disorders | 4 | 2015 | 104 | 0.870 |
Why?
|
Drug-Seeking Behavior | 3 | 2015 | 6 | 0.870 |
Why?
|
Risk-Taking | 3 | 2016 | 32 | 0.760 |
Why?
|
Adrenergic alpha-Antagonists | 2 | 2011 | 9 | 0.750 |
Why?
|
Parkinson Disease | 4 | 2020 | 1164 | 0.730 |
Why?
|
HIV Infections | 3 | 2017 | 970 | 0.720 |
Why?
|
Cues | 5 | 2015 | 61 | 0.710 |
Why?
|
Self Stimulation | 3 | 2016 | 12 | 0.680 |
Why?
|
Analgesics, Opioid | 5 | 2013 | 215 | 0.680 |
Why?
|
Antiparkinson Agents | 3 | 2017 | 130 | 0.670 |
Why?
|
Receptor, Metabotropic Glutamate 5 | 3 | 2013 | 15 | 0.660 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 3 | 2008 | 27 | 0.660 |
Why?
|
Proto-Oncogene Proteins c-fos | 4 | 2007 | 11 | 0.620 |
Why?
|
Cortical Excitability | 1 | 2015 | 2 | 0.560 |
Why?
|
Disease Models, Animal | 7 | 2015 | 729 | 0.550 |
Why?
|
Pyridines | 2 | 2012 | 42 | 0.540 |
Why?
|
Analysis of Variance | 6 | 2012 | 321 | 0.540 |
Why?
|
Basal Forebrain | 1 | 2015 | 2 | 0.540 |
Why?
|
GABAergic Neurons | 1 | 2015 | 6 | 0.530 |
Why?
|
Reward | 6 | 2015 | 34 | 0.530 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 1 | 2014 | 1 | 0.520 |
Why?
|
Drug Inverse Agonism | 1 | 2014 | 2 | 0.520 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 2 | 2013 | 3 | 0.510 |
Why?
|
Neurocognitive Disorders | 1 | 2015 | 19 | 0.510 |
Why?
|
Extinction, Psychological | 2 | 2011 | 15 | 0.500 |
Why?
|
Fendiline | 1 | 2013 | 2 | 0.490 |
Why?
|
Space Perception | 1 | 2013 | 28 | 0.480 |
Why?
|
Calcium Channel Blockers | 1 | 2013 | 36 | 0.470 |
Why?
|
Dopaminergic Neurons | 1 | 2014 | 44 | 0.470 |
Why?
|
Brain Chemistry | 1 | 2013 | 47 | 0.460 |
Why?
|
Hyperkinesis | 1 | 2013 | 11 | 0.460 |
Why?
|
Oxidopamine | 5 | 2016 | 24 | 0.450 |
Why?
|
Amphetamine | 3 | 2007 | 13 | 0.450 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2016 | 438 | 0.450 |
Why?
|
Parkinsonian Disorders | 1 | 2016 | 217 | 0.450 |
Why?
|
Morphine Dependence | 1 | 2012 | 2 | 0.440 |
Why?
|
Serotonin Antagonists | 1 | 2012 | 19 | 0.440 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2012 | 25 | 0.440 |
Why?
|
Indoles | 1 | 2012 | 48 | 0.430 |
Why?
|
Probability Learning | 1 | 2012 | 1 | 0.430 |
Why?
|
Receptors, GABA-B | 1 | 2011 | 3 | 0.420 |
Why?
|
Baclofen | 1 | 2011 | 15 | 0.400 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2012 | 23 | 0.400 |
Why?
|
GABA-B Receptor Agonists | 1 | 2010 | 2 | 0.390 |
Why?
|
Electric Stimulation | 4 | 2015 | 83 | 0.390 |
Why?
|
Receptors, Opioid, mu | 3 | 2008 | 6 | 0.370 |
Why?
|
Glutamic Acid | 2 | 2006 | 32 | 0.360 |
Why?
|
Ventral Tegmental Area | 2 | 2014 | 12 | 0.340 |
Why?
|
Oncogene Proteins v-fos | 1 | 2008 | 1 | 0.340 |
Why?
|
Basal Ganglia | 1 | 2008 | 29 | 0.330 |
Why?
|
Amphetamine-Related Disorders | 3 | 2013 | 10 | 0.330 |
Why?
|
Receptors, Serotonin, 5-HT2 | 1 | 2008 | 1 | 0.320 |
Why?
|
Time Factors | 6 | 2013 | 1614 | 0.320 |
Why?
|
Mental Disorders | 1 | 2010 | 140 | 0.320 |
Why?
|
Receptors, Dopamine D2 | 2 | 2020 | 18 | 0.310 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2006 | 7 | 0.300 |
Why?
|
6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2006 | 2 | 0.300 |
Why?
|
Conditioning, Classical | 1 | 2006 | 7 | 0.300 |
Why?
|
Social Environment | 1 | 2006 | 79 | 0.280 |
Why?
|
Narcotics | 1 | 2006 | 34 | 0.280 |
Why?
|
Immunohistochemistry | 5 | 2012 | 392 | 0.270 |
Why?
|
Blotting, Western | 3 | 2013 | 170 | 0.270 |
Why?
|
Hippocampus | 2 | 2007 | 276 | 0.260 |
Why?
|
Pyramidal Cells | 2 | 2015 | 44 | 0.260 |
Why?
|
Humans | 14 | 2020 | 29334 | 0.250 |
Why?
|
Receptors, Dopamine D1 | 1 | 2004 | 7 | 0.250 |
Why?
|
Neural Pathways | 3 | 2014 | 83 | 0.250 |
Why?
|
Infusion Pumps, Implantable | 1 | 2002 | 13 | 0.220 |
Why?
|
Maze Learning | 1 | 2002 | 16 | 0.220 |
Why?
|
Prosencephalon | 1 | 2002 | 8 | 0.220 |
Why?
|
Excitatory Amino Acids | 1 | 2002 | 1 | 0.220 |
Why?
|
Receptors, Opioid, kappa | 1 | 2002 | 3 | 0.210 |
Why?
|
Serotonin Receptor Agonists | 2 | 2013 | 9 | 0.200 |
Why?
|
Receptors, Serotonin | 2 | 2012 | 21 | 0.200 |
Why?
|
Receptors, Dopamine D3 | 1 | 2020 | 5 | 0.190 |
Why?
|
Drug Administration Routes | 2 | 2013 | 12 | 0.180 |
Why?
|
Memory | 2 | 2013 | 318 | 0.180 |
Why?
|
Delay Discounting | 2 | 2016 | 24 | 0.170 |
Why?
|
Iontophoresis | 3 | 2004 | 7 | 0.170 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2017 | 16 | 0.150 |
Why?
|
Sympatholytics | 2 | 2008 | 14 | 0.150 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2017 | 54 | 0.150 |
Why?
|
Levodopa | 1 | 2017 | 142 | 0.140 |
Why?
|
Rats, Transgenic | 1 | 2015 | 21 | 0.140 |
Why?
|
Random Allocation | 1 | 2016 | 146 | 0.140 |
Why?
|
Rats, Inbred F344 | 1 | 2015 | 48 | 0.140 |
Why?
|
Benzazepines | 2 | 2006 | 8 | 0.130 |
Why?
|
Hypothalamus | 1 | 2015 | 6 | 0.130 |
Why?
|
Self-Control | 1 | 2015 | 7 | 0.130 |
Why?
|
Personality Disorders | 1 | 2015 | 19 | 0.130 |
Why?
|
Electrophysiology | 2 | 2008 | 130 | 0.130 |
Why?
|
Biophysics | 2 | 2012 | 38 | 0.130 |
Why?
|
Microvessels | 1 | 2014 | 16 | 0.130 |
Why?
|
Personality | 1 | 2015 | 68 | 0.120 |
Why?
|
Organ Culture Techniques | 1 | 2014 | 31 | 0.120 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2006 | 49 | 0.120 |
Why?
|
Rotarod Performance Test | 1 | 2013 | 8 | 0.120 |
Why?
|
Avoidance Learning | 1 | 2013 | 9 | 0.120 |
Why?
|
Pyrazines | 1 | 2013 | 10 | 0.120 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2013 | 2 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2015 | 218 | 0.120 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2004 | 36 | 0.120 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2013 | 38 | 0.110 |
Why?
|
Substantia Nigra | 1 | 2014 | 148 | 0.110 |
Why?
|
Secondary Prevention | 1 | 2013 | 63 | 0.110 |
Why?
|
Cytokines | 1 | 2015 | 347 | 0.110 |
Why?
|
Aminopyridines | 1 | 2012 | 3 | 0.110 |
Why?
|
Reinforcement Schedule | 1 | 2012 | 2 | 0.110 |
Why?
|
Quinolines | 1 | 2012 | 16 | 0.110 |
Why?
|
Exploratory Behavior | 1 | 2012 | 18 | 0.110 |
Why?
|
Thiazoles | 1 | 2012 | 35 | 0.110 |
Why?
|
Adrenergic Agents | 1 | 2012 | 2 | 0.110 |
Why?
|
Hypoxia, Brain | 1 | 2011 | 14 | 0.110 |
Why?
|
Refractory Period, Electrophysiological | 1 | 2011 | 6 | 0.110 |
Why?
|
Evoked Potentials, Motor | 1 | 2011 | 10 | 0.100 |
Why?
|
Neural Inhibition | 1 | 2011 | 10 | 0.100 |
Why?
|
Electrodes, Implanted | 1 | 2012 | 46 | 0.100 |
Why?
|
Motor Cortex | 1 | 2011 | 17 | 0.100 |
Why?
|
Probability | 1 | 2011 | 94 | 0.100 |
Why?
|
Synaptophysin | 2 | 2007 | 9 | 0.100 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 223 | 0.100 |
Why?
|
Drug Interactions | 1 | 2010 | 67 | 0.100 |
Why?
|
Cyclopentanes | 1 | 2010 | 4 | 0.100 |
Why?
|
Phenols | 1 | 2010 | 8 | 0.100 |
Why?
|
beta Catenin | 1 | 2011 | 46 | 0.100 |
Why?
|
Pyrimidines | 1 | 2010 | 21 | 0.100 |
Why?
|
Neuronal Plasticity | 1 | 2010 | 43 | 0.100 |
Why?
|
Psychomotor Performance | 1 | 2012 | 216 | 0.090 |
Why?
|
Cerebrovascular Disorders | 1 | 2011 | 132 | 0.090 |
Why?
|
Brain Mapping | 1 | 2011 | 195 | 0.090 |
Why?
|
Signal Transduction | 2 | 2011 | 486 | 0.090 |
Why?
|
Reproducibility of Results | 1 | 2012 | 788 | 0.090 |
Why?
|
Emotions | 1 | 2010 | 90 | 0.090 |
Why?
|
Taste | 1 | 2008 | 4 | 0.090 |
Why?
|
Social Behavior | 1 | 2010 | 98 | 0.090 |
Why?
|
Photomicrography | 1 | 2008 | 1 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 28 | 0.080 |
Why?
|
Bicuculline | 1 | 2008 | 1 | 0.080 |
Why?
|
GABA Antagonists | 1 | 2008 | 3 | 0.080 |
Why?
|
N-Methylaspartate | 1 | 2008 | 4 | 0.080 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2008 | 3 | 0.080 |
Why?
|
Somatostatin | 1 | 2008 | 5 | 0.080 |
Why?
|
Microinjections | 1 | 2008 | 6 | 0.080 |
Why?
|
Narcotic Antagonists | 1 | 2008 | 14 | 0.080 |
Why?
|
Catheterization | 1 | 2008 | 48 | 0.080 |
Why?
|
Phosphorylation | 1 | 2008 | 172 | 0.080 |
Why?
|
Telencephalon | 1 | 2007 | 2 | 0.080 |
Why?
|
Cell Proliferation | 1 | 2008 | 201 | 0.080 |
Why?
|
Risk Factors | 1 | 2014 | 2436 | 0.080 |
Why?
|
Up-Regulation | 1 | 2008 | 177 | 0.070 |
Why?
|
2-Amino-5-phosphonovalerate | 1 | 2006 | 3 | 0.070 |
Why?
|
Receptors, Glutamate | 1 | 2006 | 5 | 0.070 |
Why?
|
Injections, Intraperitoneal | 1 | 2006 | 13 | 0.070 |
Why?
|
Injections, Subcutaneous | 1 | 2006 | 32 | 0.070 |
Why?
|
Injections | 1 | 2006 | 54 | 0.070 |
Why?
|
Mental Recall | 1 | 2006 | 74 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2006 | 49 | 0.070 |
Why?
|
Alcoholism | 1 | 2005 | 83 | 0.060 |
Why?
|
Sulpiride | 1 | 2004 | 1 | 0.060 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2004 | 1 | 0.060 |
Why?
|
Dopamine Antagonists | 1 | 2004 | 14 | 0.060 |
Why?
|
Time | 1 | 2004 | 18 | 0.060 |
Why?
|
Binding Sites | 1 | 2004 | 73 | 0.060 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2004 | 83 | 0.060 |
Why?
|
Functional Laterality | 1 | 2004 | 91 | 0.060 |
Why?
|
Reserpine | 1 | 2002 | 1 | 0.050 |
Why?
|
Infusion Pumps | 1 | 2002 | 16 | 0.050 |
Why?
|
Electrochemistry | 1 | 2002 | 44 | 0.050 |
Why?
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2002 | 1 | 0.050 |
Why?
|
Evoked Potentials | 1 | 2002 | 18 | 0.050 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2002 | 34 | 0.050 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2002 | 17 | 0.050 |
Why?
|
Cell Count | 2 | 2015 | 99 | 0.050 |
Why?
|
United States | 1 | 2005 | 2331 | 0.040 |
Why?
|
Intracellular Space | 1 | 2015 | 8 | 0.030 |
Why?
|
Spleen | 1 | 2015 | 50 | 0.030 |
Why?
|
Receptors, Endothelin | 1 | 2014 | 5 | 0.030 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2014 | 9 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 16 | 0.030 |
Why?
|
Vasoconstriction | 1 | 2014 | 24 | 0.030 |
Why?
|
Membrane Potentials | 1 | 2015 | 189 | 0.030 |
Why?
|
Hypoxia | 1 | 2014 | 60 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2014 | 101 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 343 | 0.030 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2011 | 5 | 0.030 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2011 | 17 | 0.030 |
Why?
|
Electromyography | 1 | 2011 | 78 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 145 | 0.020 |
Why?
|
AIDS Dementia Complex | 1 | 2011 | 41 | 0.020 |
Why?
|
Down-Regulation | 1 | 2011 | 115 | 0.020 |
Why?
|
Cell Line | 1 | 2011 | 299 | 0.020 |
Why?
|
Astrocytes | 1 | 2011 | 122 | 0.020 |
Why?
|
Comorbidity | 1 | 2011 | 497 | 0.020 |
Why?
|
Biomarkers | 1 | 2011 | 690 | 0.020 |
Why?
|
Dentate Gyrus | 1 | 2007 | 8 | 0.020 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2007 | 8 | 0.020 |
Why?
|
Neostriatum | 1 | 2007 | 22 | 0.020 |
Why?
|
Amygdala | 1 | 2007 | 52 | 0.020 |
Why?
|
Receptor, trkB | 1 | 2006 | 3 | 0.020 |
Why?
|
Young Adult | 1 | 2011 | 1933 | 0.020 |
Why?
|
Adult | 1 | 2011 | 8593 | 0.010 |
Why?
|
Middle Aged | 1 | 2011 | 9817 | 0.010 |
Why?
|
Female | 1 | 2011 | 16202 | 0.010 |
Why?
|